1. Glycopeptides and glycolipids were isolated from normal cat liver and liver from a cat affected with GM1 gangliosidosis. 2. Bio-Gel P-6 chromatography ofthe crude glycopeptide fractions demonstrated three major peaks of hexose-containing compounds that were greatly increased in the mutant liver sample; these peaks contained oligosaccharides that comprised over 2% of the liver wet weight. 3. Two of the major pathological oligosaccharides, GP5 and GP6, were purified by chromatography on charcoal/Celite and Sephadex G-25. Oligosaccharides GP5 and GP6 had apparent mol
1. Glycopeptides and glycolipids were isolated from normal cat liver and liver from a cat affected with GM1 gangliosidosis. 2. Bio-Gel P-6 chromatography ofthe crude glycopeptide fractions demonstrated three major peaks of hexose-containing compounds that were greatly increased in the mutant liver sample; these peaks contained oligosaccharides that comprised over 2% of the liver wet weight. 3. Two of the major pathological oligosaccharides, GP5 and GP6, were purified by chromatography on charcoal/Celite and Sephadex G-25. Oligosaccharides GP5 and GP6 had apparent mol.wts. of 1800 + 200 and 1350 + 200 respectively, and contained galactose, mannose and Nacetylglucosamine in molar proportions of 2.0:3.1:4.1 (GP5) and 1.0:2.2:2.7 (GP6). Periodate oxidation studies demonstrated the presence of galactose in a non-reducing terminal position. 4. The neutral glycolipid fraction from the mutant cat liver has a 1.3-fold increase in hexose content accompanied by an increased concentration of asialo-(ganglioside GM1). 5. There was a 2-fold increase of gangliosides in the mutant cat liver compared with normal cats. Ganglioside GM1 and a compound tentatively identified as N-glycolloyl-(ganglioside GM1) were the major glycolipids accumulated. GM1* gangliosidosis is an inherited lysosomal storage disorder resulting from a deficiency of the enzyme acid fl-D-galactosidase (O'Brien, 1978a) . A prominent feature of the disease is the accumulation of ganglioside GM1 in the brain and visceral tissues of affected individuals (Landing et al., 1964; Suzuki et al., 1969; Wolfe et al., 1970; Lowden et al., 1973) . Several classes of non-lipid storage compounds have also been isolated from a number of human patients. These include partially degraded keratan sulphates (Suzuki etal., 1969; Tsay & Dawson, 1973; Calatroni, 1974) and oligosaccharides or glycopeptides that appear to derive from cellular glycoproteins (Brunngraber et al., 1976; Calatroni, 1974; Wolfe et al., 1974) . GM1 gangliosidosis occurs in cats as well as humans (Handa & Yamakawa, 1971; Blakemore, 1972; Farrell et al., 1973; Cheetham et al., 1974) . Among the many similarities between the human and cat disorders are the near-total deficiency of acid fl-galactosidase and histological evidence for the accumulation of storage products in the brain and viscera of affected cats (Baker et al., 1976) . Although hepatic ganglioside storage has been demonstrated in the cat disorder (Handa & Yamakawa, 1971; Blakemore, 1972; Baker et al., 1976) , a comprehensive examination of the storage material in visceral tissues has not been reported. The present study was hexoside were purified from tissues obtained after autopsy of patients with Gaucher's and Fabry's disease respectively. Asialo-(ganglioside GM1) was prepared by mild acid hydrolysis of purified bovine brain ganglioside GM1.
Methods
Initial fractionation of liver tissue. Glycopeptide, upper-phase lipid, lower-phase lipid and glycosaminoglycan fractions were prepared from 2 g samples of liver from mutant and normal cats as previously described (Brunngraber et al., 1971) . Briefly, the method involved: (a) homogenization of tissue in 19vol. ofchloroform/methanol (2: 1, v/v) followed by re-homogenization of the tissue residue in lOvol. of chloroform/methanol (1:2, v/v); (b) partitioning of the combined organic extracts (total-lipid fraction) with an aq. KCI solution to prepare upper-and lowerphase-lipid fractions; (c) extensive digestion of the lipid-free tissue residue with papain; and (d) precipitation of glycosaminoglycans from the proteolytic digest (glycopeptide fraction) with cetylpyridinium chloride. The original procedure was modified in the desalting of the proteolytic digest that, in this study, was accomplished in an ultrafiltration cell over a UM-2 membrane. The upper-phase-lipid fractions were dialysed against water at 40C and freeze-dried. The lower-phase-lipid fractions were saponified (Abramson et al., 1965) before analysis. Protein determinations were by the method of Lowry et al. (1951) , with bovine serum albumin as a standard. Total hexosamine was determined by the method of Levvy & McAllen (1959) , with N-acetylglucosamine as standard, after hydrolysis of the samples in 4M-HCI for 6h at 100°C.
Fractionation of the glycopeptides. The liver glycopeptides from one mutant animal and three normal animals were fractionated by gel filtration on a bed (2.Ocmx 87cm) of Bio-Gel P-6 at 230C. Samples (3.5 ml) were applied and eluted with water at a flow rate of 32ml/h and 4.Oml fractions were collected. The fractions were assayed for total hexose by the phenol/H2SO4 method (Dubois et al., 1956) , with galactose as standard. Amino groups were determined with the trinitrobenzenesulphonic acid assay (McKelvy & Lee, 1969) relative to a glycine standard. Various column fractions were analysed for carbohydrate by g.l.c. as described below.
Glycopeptide fractions were analysed by ascending t.l.c. on plates (10cm x 20cm) of silica-gel 60 by using the solvent system propan-1-ol/acetic acid/ water (3:3:2, by vol.) (running time 12-16h). A square of filter paper was clamped to the top 2cm of the plate to permit extended development. After drying, the plates were stained for sugar-containing compounds by spraying with orcinol (1% in 50% H2SO4) and heating for 10min at 100°C.
The three major peaks of carbohydrate-containing material resolved by Bio-Gel chromatography of the mutant glycopeptide fraction were further purified by chromatography on charcoal/Celite (Spiro, 1966) . Samples were applied in water (1mg of hexose/ml bed vol.) and eluted stepwise with increasing concentrations of ethanol in water at 230C. The eluted fractions were decreased in volume in a rotary evaporator and analysed for hexose by the phenol/H2SO4 assay. The fractions were analysed by t.l.c. as described above and those that appeared homogeneous were used for further purification.
Peak fractions from the charcoal columns (compounds GP5 and GP6) were next chromatographed at 230C on a column (2.0cmx87cm) of Sephadex G-25 (medium mesh) with O.1M-acetic acid as the eluent at a flow rate of 24ml/h. The column was calibrated with carbohydrate standards of various molecular weights (Bhatti & Clamp, 1968) . The peak fractions from this column were pooled and used for the final analyses of compounds GP5 and GP6.
Analysis of the glycopeptides. The carbohydrate compositions of crude and purified fractions were determined by g.l.c. analysis of the trimethylsilyl derivatives of the monosaccharide methyl glycosides, which were prepared and chromatographed as described by Clamp et al. (1971) , except for the following modifications. (a) Methanolysis was carried out in methanolic 1.5M-HCI (0.5ml) at 80°C for 12h in vials with Teflon-lined screw caps; (b) the methanolysates were neutralized with 0.15ml of anhydrous pyridine and acetylated for 1 h at 23°C by adding 0.lOml of acetic anhydride; and (c) the samples were thoroughly dried in a vacuum desiccator over phosphoric oxide and silylated by using 'silylating agent a' (Clamp et al., 1971) . Mannitol was included in the samples as the internal standard. Analyses were carried out on a Nuclear-Chicago Selecta System 5000 gas-liquid chromatograph equipped with a flame-ionization detector and a column (2mmx2m) of 3% SE-30 on 100/120 GasChrom Q (Applied Science Laboratories, State College, PA, U.S.A.).
Periodate oxidation of the purified compounds was carried out by the method of Tsay et al. (1976) . The procedure was followed by the addition of the mannitol standard, methanolysis and g.l.c. analysis of the surviving sugars as described above.
Amino acids were analysed by g.l.c. as N(O)-heptafluorobutyrates of their isopentyl esters (Zanetta & Vincendon, 1973) (Esselman et al., 1972) . The glycolipids from cat liver were tentatively identified by their co-migration with standard compounds. Total lipid-bound sialic acid was determined by the method of Svennerholm (1957) . Neutral hexose was determined on sample zones scraped from t.l.c. plates by the anthrone method of Rouser et al. (1970) . The carbohydrate compositions of several mutantliver upper-phase glycolipids were determined by g.l.c. analysis. After separation by t.l.c. in system 2, the glycolipids were located with 12 vapour and by staining a sample on the edge of the plate with ax-naphthol. Regions were scraped from the plate and the glycolipids were eluted with chloroform/ methanol (1: 1, v/v). After filtering the eluents through a plug of glass wool, mannitol was added, and the samples were thoroughly dried. Methanolysis, conversion into derivatives and g.l.c. were carried out as described for the glycopeptides, except that the methanolysates were extracted with three 1 ml portions of hexane before neutralization.
Results

Gelfiltration ofthe crude glycopeptidefractions
The total hexosamine content of the mutantglycopeptide fraction was 10-20-fold higher than -the controls. An accompanying increase in total hexose was apparently obscured by the large amount of glycogen in all of the samples. Bio-Gel P-6 chromatography of the normal glycopeptides gave two main peaks of hexose, corresponding to the elution volumes of the Blue Dextran and galactose standards. In between these peaks were several minor peaks of hexose-containing compounds. The elution profile of the mutant glycopeptides resembled the normal controls in that both the high-and lowmolecular-weight peaks were present. However, the majority of the hexose-containing compounds in the sample from mutant liver were eluted in the intermediate fractions, where massive increases were evident (Fig. 1) .
The majority of the mutant compounds were eluted as three peaks between fractions 45 and 60. In addition, several minor hexose-containing fractions were eluted earlier, indicating the presence of several additional higher-molecular-weight species. The major peaks of glycopeptide were separated from the bulk of the peptide material that eluted in fractions 24-46 and 58-75. Carbohydrate analysis of selected fractions from the column run of mutant glycopeptides (Table 1) showed that the material that eluted in the void volume was probably a mixture of glycoproteins or large glycopeptides and glycogen. The compounds of intermediate molecular weight (fractions 42, 48, 50, 51, 55 and 56) were composed primarily of galactose, mannose and N-acetylglucosamine. The mutant-glycopeptide fractions were pooled as indicated (Fig. 1) . On the basis of phenol/H2SO4 determinations, pools 4, 5 and 6 contained 8.5, 13.5 and 9.2mg of hexose respectively. Analysis of the three pools by t.l.c. showed that each was composed of a mnajor and one or more minor constituents (Fig. 2) . These pools were used for further purification and analysis. The glycopeptide fractions from the controls were not investigated further.
Fractionation ofpooledfractions 4-6
Charcoal/Celite chromatography of pooled fractions 4-6 resulted in 80% recoveries of hexose in all cases. About 70% of the hexose recovered from Table 1 . Carbohydrate composition offractionsfrom mutant liver after Bio-GelP-6 chromatography Samples (100,ul) of selected fractions from the mutant glycopeptide fractionation (Fig. 1) Fraction no. The glycopeptide fractions were chromatographed as described under 'Methods'. Samples of the column fractions were assayed for hexose by the phenol/H2SO4 method and free amino groups by the trinitrobenzenesulphonic acid method. The results are expressed relative to galactose and glycine standards respectively. Symbols: *, hexose, mutant; o, hexose, normal; ----,amino groups, mutant. The amino-group data for the normal sample were deleted for clarity; however, the normal and mutant-liver profiles are virtually superimposable. Asterisks denote the individual mutantliver fractions that were analysed for carbohydrate by g.l.c. (Table 1 ). The mutant-liver column fractions were then combined into pools as indicated by the numbered bars at the top of the Figure. purified compounds GPS and GP6 Samples of the concentrated Bio-Gel pools (Fig. 1) or the final purified compounds (Fig. 4) pool 4 eluted in the 25 % ethanol fraction (Fig. 3a) . This fraction was not homogeneous by t.l.c. as it contained the same two constituents found in unfractionated pool 4 (Fig. 2, lane 1) . This mixture, designated compound GP4, was not purified further, but was analysed for amino acids and carbohydrates to determine the general properties of the constituents. About 60% of the hexose recovered after charcoal/Celite chromatography of pool 5 eluted in the 15 % and 20 % ethanol fractions (Fig. 3b) , both of which contained the same single component by t.l.c. These two fractions were combined and designated compound GP5. About 55 % of the hexose recovered from pool 6 eluted in the 15 % ethanol fraction (Fig. 3c) , which also contained a single component by t.l.c.; this fraction was designated compound GP6. It was estimated that compound GP5 comprised 70% of the total hexose in Bio-Gel pool 5, whereas compound GP6 comprised 65 % of the total hexose in Bio-Gel pool 6. The minor constituents of pools 5 and 6 were recovered as mixtures in other fractions of the respective charcoal/Celite columns and were not studied further.
Sephadex G-25 chromatography of compounds GP5 and GP6 gave single sharp peaks for both compounds, indicating that each was homogeneous with respect to molecular weight (Fig. 4) . Calibration of the molecular weights with respect to carbohydrate standards gave values of 1800 and 1350 for compounds GP5 and GP6 respectively. The apparent molecular weights of the pool 4 compounds were estimated to be 2100 on the basis of their elution volumes from the initial Bio-Gel column. The peak fractions from each Sephadex G-25 column were pooled and used for the final analyses. T.l.c. of the purified compounds (Fig. 2, lanes 4 and 5) , followed by scanning densitometry of the plate, showed that 95 % of the stained material in compound GP6 and 99 % of the stained material in compound GP5 were associated with single orcinol-positive bands. Characterization of compounds GP4, GP5 and GP6 Amino acid analysis. Amino acid analysis of hydrolysates of compounds GP4, GP5 and GP6 demonstrated an absence of amino acid constituents. Thus, although these compounds were isolated from a proteolytic digest of mutant liver, they apparently accumulated as oligosaccharides rather than as glycoproteins or glycopeptides.
Carbohydrate analysis. Galactose, mannose and N-acetylglucosamine were the only sugar constituents detected in methanolysates of oligosaccharides GP4, GP5 and GP6. The composition and the observed molecular weights of oligosaccharides GP5 and GP6 (Table 2) were consistent with the former being an oligosaccharide with nine sugar moieties, and the latter an oligosaccharide containing six sugars. The calculated molecular weights were in agreement with those observed on gel filtration.
Periodate oxidation. The galactose residues of oligosaccharides GP5 and GP6 (and the two Vol. 175 components of oligosaccharides GP4) were completely destroyed by periodate treatment, indicating that this sugar occupied a non-reducing terminal position in these oligosaccharides.
The partial destruction of N-acetylglucosamine in oligosaccharide GP5 indicated the presence of either terminal or internal C-6-substituted residues. In oligosaccharide GP5, 67% of the mannose residues were oxidized. The negligible quantity of erythritol among the oxidation products indicated that the oxidized mannose residues were probably single substituted at either C-2 or C-6 or di-substituted (C-2 and C-6). The surviving mannose was apparently di-substituted.
In oligosaccharide GP6, about 40% of the Nacetylglucosamine and 90 % of the mannose residues were destroyed after periodate oxidation. The oxidation products were similar to those found for oligosaccharide GP5. Thus oligosaccharide GP6 also appeared to contain terminal or internal C-6-linked N-acetylglucosamine moieties as well as mannose residues that were unsubstituted at C-3 or C-4.
Glycolipid analysis. Lower phase. Ceramide monohexoside was the major neutral glycolipid in normal cat liver, comprising about 70% of the total lipidbound hexose. The mutant-liver lower phase contained a normal amount of ceramide monohexoside, but had a 1.3-fold increase in neutral lipid-bound hexose compared with the controls. This difference was primarily due to the presence of a compound that reacted with a-naphthol but not with resorcinol and had the chromatographic mobility of asialo-(ganglioside GM,) (Fig. 5a ).
Upper phase. The mutant-liver upper phase had a 2-fold increase in total sialic acid compared with the controls (normal, 0.25-0.35,mol/g wet wt. of tissue; Fraction no. -ig. 4. Sephadex G-25 chromatography of eompounds GP5 and GP6 The major charcoal/Celite fractions from pools 5 and 6 (compounds GPS and OP6) were each chromatographed on a calibrated column ofSephaddx G-25 as described under 'Methods'. Samples (50Opl) of column fraotions were assayed for hexose by the phenol/H2SO4 method and the results are plotted as A490. Fraction volume was 1.9ml. Symbols: *, compound GP5; 0, compound GP6. The column was standardized (Bhatti & Clamp, 1968) with the following compounds (mol.wt.): galactose, 180; sucrose, 342; stachyose, 667; human GMI gangliosidosis storage oligosaccharide, 1800±200. The apparent molecular weights of compounds GP5 and GP6 were 1800±200 and 1350±200 respectively. The bars indicate the fractions that were pooled for final analysis. mUtant, 0.60,umol/g wet wt. of tissue). Analysis of normal and mutant-liver samples by t.l.c. in solvent system 1 demonstrated that the upper phase of the latter contained an increased proportion of a compound that co-migrated with bovine brain ganglioside GM1. In solvent system 2, the mutant-liver upper phase was resolved into at least seven resorcinolpositive bands that appeared increased relative to the controls (Fig. 5b) . The four most prominent components in the mutant sample migrated as two doublet bands. One doublet had the mobility of bovine brain ganglioside GM1 and the second had a mobility Intermediate between those of bovine brain gangliosides GD1a and GDlb. None of the mutant-liver oligosaccharides migrated from the origin in solvent system 2. Examination of the upper phases in solvent system 3 revealed two major bands with increased glycolipid in the mutant-liver sample. One had the mobility of the ganglioside GM1 standard and the other had a lower mobility that was distinct from those of the disialo standards.
Carbohydrate analysis of the mutant-liver upper phase glycolipids after separation by t.l.c. in solvent system 2 indicated that all four of the major species contained glucose, galactose, N-acetylglucosamine and sialic acid in the approxirnate molar proportions (1: 2: 1: 1) expected for monosialogangliosides of the ganglio-X-tetraoside series. The tnajor constituents of the material remaining at the origin in this system were mannose, galactose, N-acetylglucosamine and glucose, indicating that the non-mnigrating material was probably related to the mUtant-liver oligosaccharides. The minor bands in the mutant-liver sanmple were not analysed.
Discussion
The present results demonstrate significant hepatic accumulations of galactose-containing macromolecules in a cat with GM1 gangliosidosis. Both glycolipid and glycopeptide fractions from the mutant liver contain compounds that were not detected in normal tissue samples of comparable size.
Although a compound identified as asialo-(ganglioside GMI) was stored in mutant liver, the most impressive evidence for glycolipid pathology was found in the ganglioside fraction. Analysis by t.c.
showed that the major pathological gangliosides migrated as 1, 2 or 4 bands depending on the solvent system used. These glycolipids had the game carbohydrate composition as ganglioside GM1. One likely possibility is that the faster-and slower-migrating doublet bands are ganglioside GM1 containing Nacetyineuraminic acid and N-glycolloylneuraminic acid respectively. The N-glycolloyl derivative migrates close to ganglioside GD1a in solvent system 2 (Fong et al., 1976 ), as we observed for the more polar doublet.
Extra-neural gangliosides ofcertain species, including the cat, have been shown to contain N-acetyl and N-glycolyl sialic acids (Handa & Handa, 1965; Wiegandt, 1971) . The diversity of fatty acid compositions of extra-neural gangliosides (Puro & Huttunen, 1969) and previous reports of the effects of fatty acid and long-chain base composition on the chromatographic properties of ceramide polyhexos-1978 
(1) (2) (3) (4) (5) (6) (7) GD1a; D, ganglioside GDIb; E3, ganglioside GT; lan1eS (2) and (5), normal liver upper phase; lanes (3) and (6), mutant-liver upper phase; lanes (4) and (7) standards ganglioside GM1 and ganglioside GD1a. Lanes (1)- (4) were detected with ac-naphthol and lanes (5)- (7) with resorcinol. The solvent system was chloroform/methanol/2.5M-NH3 (60:40:9, by vol.).
ides (Hakomori, 1966; Wiegandt & Bucking, 1970) could explain the double bands observed for compounds. The limited amount of mutant tissue available for analysis in the present study did not permit conclusive identification of the accumulated glycolipids and these structural proposals remain tentative.
The extent of oligosaccharide storage in the mutant liver was particularly striking. The three major abnormal peaks of material from Bio-Gel chromatoVol. 175 graphy contained neutral hexose equivalent to about 2 % of the tissue wet weight. The presence of highermolecular-weight hexose-containing compounds (pools 2 and 3 from Bio-Gel chromatography) and the heterogeneity of the three major pools is an indication of the wide variety of galactose-containing compounds that accumulate as a result of the enzyme defect. All of the pathological oligosaccharides have the same major sugar constituents, but they appear to differ both in size and structure. Oligosaccharide storage occurs in human metabolic disorders due to deficiences of fl-galactosidase (Wolfe et al., 1974) , a-fucosidase (Tsay et al., 1976) and sialidase (Strecker et al., 1977; O'Brien, 1978b) . In each instance the pathological oligosaccharides have similar internal structures, but differ in their chain lengths and non-reducing termini, depending on which hydrolase activity is deficient. The structures of some of these human storage compounds suggest that they are derived from the asparaginelinked oligosaccharide chains of naturally occurring glycoproteins, such as erythrocyte stromal glycoprotein and the immunoglobulins (Wolfe & Ng Ying Kin, 1976) . By analogy, the storage oligosaccharides in cat liver may have similar origins.
The two major storage oligosaccharides in the cat appear to be similar to compounds isolated from human GM, gangliosidosis liver and urine (Wolfe & Ng Ying Kin, 1976 ) with respect to carbohydrate composition and molecular weight. However, the oligosaccharides from cat contain a higher ratio of N-acetylglucosamine to galactose as well as periodatesensitive N-acetylglucosamine residues. Further, both oligosaccharides GP5 and GP6 were distinct from the major human storage oligosaccharide on t.l.c. (E. W. Holmes & J. S. O'Brien, unpublished work). Perhaps the differences between the cat and human compounds reflect species differences in the oligosaccharide structures of the glycoproteins from which they originate.
The compositional and periodate oxidation data suggest that the hexasaccharide GP6 may have the structure: (*,-.lGal)GlcNAc1l 2(6)Manl 2(6)Man-(1GlcNAc) with an additional N-acetylglucosamine linked to either of the two mannose residues at C-2 or C-6. This tentative structure has a terminal fl-linked galactose as indicated by the periodate studies, in keeping with the fl-D-galactosidase deficiency in the mutant animal. The two periodate-sensitive mannose residues would give rise to glycerol on oxidation (unsubstituted at C-3 and C-4) as observed. Since 40% of the N-acetylglucosamine residues were periodate-sensitive, this suggests that one of the three is in a terminal position. The oligosaccharide GP5 might represent an elaboration of this structure containing an additional (+-fllGal)GlcNAc1 -+2Man linked (at C-3 or C-4) to either of the monosubstituted mannose residues, protecting it from oxidation. Linkage ofthis trisaccharide to the internal mannose of the proposed structure would form a branched trimannosyl core similar to that found in the human storage oligosaccharides (Wolfe et al., 1974; Tsay et al., 1976) . The structural heterogeneity indicated by the incomplete oxidation of mannose residues in oligosaccharide GP6 and the partial oxidation of N-acetylglucosamine residues in oligosaccharide GP5, as well as the possibility of minor compositional heterogeneity in both compounds, require that additional structural studies be carried out to elucidate the precise structures.
Recent studies of human GM1 gangliosidosis (Tsay & Dawson, 1973; Calatroni, 1974; Wolfe & Ng Ying Kin, 1976) suggest that keratan sulphate is not stored in the viscera of patients; however, the storage of ketatan sulphate-related glycopeptides has been reported in some cases (Tsay & Dawson, 1973; Calatroni, 1974) , but not in others (Wolfe & Ng Ying Kin, 1976) . Initial studies of the glycosaminoglycan fractions from normal and mutant cat liver revealed no major differences, but, because the method of tissue fractionation did not ensure the quantitative recovery of keratan sulphate, we cannot rule out the possibility of hepatic keratan sulphate storage in the mutant cat. In fact, some of the carbohydrate-containing compounds in the void volume after Bio-Gel chromatography of the mutant-liver glycopeptides may be keratan sulphates that were not precipitated by cetylpyridinium chloride. Bio-Gel chromatography of the mutant-liver glycopeptides indicated that keratan sulphate-related glycopeptides (Tsay & Dawson, 1973) are not among the major hepatic storage compounds in mutant cats. Further analysis of the storage compounds from affected cats and humans may resolve the conflict over this aspect of the biochemical pathology in GM1 gangliosidosis.
The similarities in the biochemical pathology of cat and human GM1 gangliosidosis is further evidence for the suitability of the cat as a model system for the study of the clinical, biochemical and genetic aspects of this rare storage disorder. The cat model may also be useful in the development of techniques for therapeutic intervention in the lysosomal storage disorders. A decrease in the tissue storage or urinary excretion of the pathological oligosaccharides described in this report would seem to offer a sensitive method for assessing the success of various kinds of corrective therapy.
